NcXHF

RIOTH, OSTERMAN, AND WARNER
TABLE 1. Major Organizations with Content Useful to Practicing Oncologists
Organization Name Acronym URL Notes
American Cancer Society ACS cancer.org
American College of Surgeons AcoS facs.org Includes the Commission on Cancer and the National Cancer
Data Base
American Joint Committee on Cancer AJCC cancerstaging.org Staging rules for most solid and some hematologic malignancies
American Society for Radiation Oncology ASTRO astro.org
American Society of Hematology ASH hematology.org ASH Image Bank; access to ASH proceedings
Centers for Disease Control and Prevention CDC cdc.gov/cancer Information about cancer statistics and more
College of American Pathologists CAP cap.org Resources about genomics and molecular medicine
European Hematology Association EHA ehaweb.org Free online access to EHA proceedings
European Society for Medical Oncology ESMO esmo.org Free online access to ESMO proceedings
National Cancer Institute at the National NCI
cancer.gov
Institutes of Health
National Comprehensive Cancer Network NCCN nccn.org Extensive set of regularly updated guidelines for most cancer
subtypes
Oncology Nursing Society ONS ons.org
Radiological Society of North America RSNA rsna.org
practitioners. Unfortunately, oftentimes the result is a needless
duplication of effort. Here, we focus on a few mostly notfor-profıt
endeavors that offer a fairly unique, extensive, or
centralized source of information.
HemOnc.org
This knowledge base for chemotherapy regimens and antineoplastic
drugs began 2011 as a freely available collaborative
resource for oncologists and oncology professionals. Similar
to Wikipedia, users can edit, create, and delete pages at will.
Unlike Wikipedia, an additional stipulation that users be
oncology professionals is required; there are currently 26
users with editing privileges. As of this writing, there are
1,390 chemotherapy regimens (1,865 when including variants)
covering 70 benign and malignant disease conditions.
To our knowledge, HemOnc.org is the largest freely
FIGURE 3. A Screenshot from HemOnc.org of R-CHOP for Untreated Follicular Lymphoma 35
For each regimen variant, a table has a link directly to the original published article and links to comparator regimens in the case of randomized trials (as shown here). Level of evidence and
comparative efficacy as reported in the original literature (for randomized trials) are shown using a simple green-yellow-red schema. Below this table, the regimen details are shown with links
to individual drug pages for each drug. When relevant, additional links to external sites are provided, such as the link to the ASCO guidelines for the use of G-CSF. Not shown are five
additional R-CHOP variants, 10 references to the original studies, and two references to updates of the original studies.
e612
2015 ASCO EDUCATIONAL BOOK | asco.org/edbook